Sign in

Christelle Gedeon

Chief Legal Officer and Corporate Secretary at Canopy Growth
Executive

About Christelle Gedeon

Chief Legal Officer and Corporate Secretary of Canopy Growth Corporation (CGC). Age 44 as of the 2025 proxy record date; joined CGC in August 2022. She oversees Legal, Government Affairs, Regulatory and Quality, Corporate Development, Business Intelligence, and strategy, and led the development of the Canopy USA structure; previously completed 50+ M&A/strategic investments and holds an LL.B/B.C.L. (McGill) and a Ph.D. in Clinical Pharmacology & Toxicology (University of Toronto) . Fiscal 2025 company outcomes tied to her leadership across strategy and regulatory execution included consolidated gross margin expansion (+300 bps), Canada Cannabis gross margin expansion (+700 bps), SG&A down 18% (ex‑divestitures), and total debt reduced by C$293mm (49%); Canada medical revenue grew 16% YoY .

Past Roles

OrganizationRoleYearsStrategic Impact
Aphria, Inc.Chief Legal Officer & Corporate Secretary2018–2021Senior legal leadership in cannabis; executed M&A and managed complex regulatory structures .
The Metals CompanyChief Legal Officer2021–2022Governance and legal leadership in deep‑sea mining; complex regulatory oversight .
Fasken Martineau DuMoulin LLPPartnerPre‑2018Corporate/regulatory practice; IP, governance, government relations; built transaction execution capabilities .

External Roles

  • Not disclosed in CGC’s 2025 and 2024 proxy officer biographies for Gedeon .

Fixed Compensation

ComponentDetail
Base salary (on hire)C$485,000 (approx. US$366,854) effective Aug 1, 2022; C$65,000 (approx. US$49,166) sign‑on bonus .
Base salary adjustmentsC$509,250 effective Jun 1, 2023 (approx. US$385,196); C$535,000 effective Aug 21, 2023 (approx. US$395,151) .
FY2025 base salaryC$535,000; 0% change vs FY2024 per NEO base salary table .
Target annual bonus (STIP)75% of base salary; 0–200% payout leverage based on financial/operational/strategic/individual objectives approved by CGCN Committee .
Target LTI200% of base salary annually (mix of Options/RSUs/PSUs at Committee discretion) .
Retention bonusUS$150,000 retention if employed through Oct 1, 2025; payable on next payroll post‑End Date; also payable if terminated without cause before End Date; documented Aug 19, 2024 .

Summary Compensation (NEO table amounts; USD)

MetricFY2023FY2024FY2025
Salary$232,812 $383,454 $371,880
Bonus (sign‑on/other)$157,444
Stock awards (RSUs/PSUs grant date FV)$357,668 $375,977 $388,737
Option awards (grant date FV)$554,908 $479,289 $364,767
Non‑equity incentive (STIP)$454,884 $216,411
All other compensation$693
Total$1,302,831 $1,693,604 $1,342,488

Performance Compensation

FY2025 STIP Design, Performance, and Payout

MetricWeightTargetActual AchievementWeighted Result
Adjusted EBITDA45% Company target 29.3% of target 13.2%
Revenue25% Company target 17.6% of target 4.4%
Other corporate objectives30% Committee‑set objectives 200% (superior) 60.0%
Total payout factor100%77.6% of target
  • Gedeon FY2025 bonus: Target 75% of salary; payout 77.6% of target; USD $216,411; paid July 11, 2025 .

FY2025 Long‑Term Incentive Awards (granted June 10, 2024)

Grant dateAward type# UnitsExercise priceVestingTermGrant date FV (USD)
2024‑06‑10RSU51,217 1/3 on Jun 15, 2025/2026/2027 $388,737
2024‑06‑10Option43,163 $7.59 1/3 on each of 1st–3rd anniversaries 6 years $250,413
2024‑06‑10Option19,144 $7.59 1/3 on each of 1st–3rd anniversaries 6 years $114,354
  • FY2026 LTI plan design: CLO total LTI accrual 200% of salary; 100% RSUs, 100% Options (split shown as % of salary) .

Equity Ownership & Alignment

Beneficial Ownership (as of Aug 1, 2025)

ItemAmount
Common shares held directly21,042
Options exercisable within 60 days159,828
RSUs vesting within 60 days30,312
PSUs vesting within 60 days8,111
Total beneficial ownership (SEC definition)219,293
Percent of class<1%
  • Ownership guidelines: CLO required to hold 3x base salary; five‑year accumulation period; includes shares and RSUs .
  • Hedging/Pledging: Insider Trading Policy prohibits hedging transactions; no disclosure of pledging; no hedging transactions reported by officers/directors .
  • Near‑term vesting/supply: Within 60 days of Aug 1, 2025, 38,423 units (30,312 RSUs + 8,111 PSUs) scheduled to vest, potentially adding short‑term liquidity needs for tax/withholding .

Selected Outstanding Awards Detail (Gedeon)

Grant dateOption status (Exercisable/Unexercisable)Exercise priceExpiryRSU/PSU unvested
2022‑08‑1010,811 / 5,405 options C$37.00 2028‑08‑10
2022‑08‑106,667 / 3,333 options C$37.00 2028‑08‑10
2022‑11‑223,327 / 1,663 options C$53.90 2028‑11‑22
2023‑06‑2854,758 / 77,258 options C$6.20 2029‑06‑28
2023‑06‑28— / 32,258 options C$6.20 2029‑06‑28
2023‑08‑2260,624 RSUs unvested value C$80,630 at filing ref
2024‑06‑10— / 19,144 options US$7.59 2030‑06‑10
2024‑06‑10— / 43,163 options US$7.59 2030‑06‑10 51,217 RSUs unvested; US$46,607 market value reference

Employment Terms

TermKey Provisions
Employment agreementEffective Aug 1, 2022; CLO reports to CEO .
STIPTarget 75% of base; 0–200% based on financial/operational/strategic/individual goals .
LTIAnnual target 200% of salary; awards may include Options/RSUs/PSUs; mix at Committee discretion .
Severance (without cause)Lump sum equal to 18 months’ base salary; plus 150% of average of prior two years’ actual STIP; PSUs vest at actual performance for certified years; statutory benefits continuation (ESA) .
Non‑compete/Non‑solicit18 months post‑termination .
RetentionUS$150,000 retention through Oct 1, 2025; also payable upon without‑cause termination before End Date .
ClawbackBoard may recoup for cause, misconduct, harm, or restatement; standalone policy aligned to U.S. rules updated in FY2025 .
Anti‑hedgingHedging transactions prohibited for officers/directors .

Estimated Payments (as of March 31, 2025)

ScenarioCash Payment (USD)Accelerated Awards (USD)Benefits (USD)Total (USD)
Termination without cause$1,049,352 (includes 18 months salary, 1.5x average STI, retention award, statutory vacation per note) $2,793 $4,375 $1,056,520
Termination within 18 months of Change in Control$1,049,352 $110,488 (unvested RSUs/PSUs/Options accelerate; PSUs at certified levels/on‑target where uncertified) $4,375 $1,164,215

Notes: Employment agreements do not provide separate cash payments solely upon CIC; equity acceleration requires termination within 18 months post‑CIC per Omnibus Plan (i.e., double‑trigger for awards) .

Performance & Track Record

  • Strategic leadership: Led Canopy USA structure; ongoing advocacy to improve Canada cannabis regulatory framework; instrumental to profitability strategy .
  • Deal execution: Completed 50+ M&A/strategic investments in prior roles; recognized among Canada’s Law Department Leaders of the Year; Legal 500 GC 2020 Powerlist; CGCA Tomorrow’s Leader (2019) .
  • FY2025 corporate outcomes: Consolidated gross margin +300 bps; Canada Cannabis gross margin +700 bps; SG&A −18% (ex‑divestitures); total debt −C$293mm (49%); Canada medical revenue +16% YoY .

Governance, Say‑on‑Pay, and Policies

  • Ownership guidelines: CLO required to 3x salary in share interests within five years .
  • Say‑on‑Pay 2025: Advisory approval; votes for 31,703,479; against 5,776,826; abstain 1,157,744 (with broker non‑votes) .
  • Risk‑mitigating practices: Majority at‑risk pay, multi‑year vesting, capped STIP, independent consultant (Mercer), updated clawback .
  • Section 16 compliance: One Form 4 filing for Gedeon was inadvertently filed late in FY2024 (company‑reported) .

Investment Implications

  • Pay‑for‑performance linkage: Cash bonus scaled down to 77.6% of target due to underachievement on revenue and Adjusted EBITDA, while corporate objectives scored at 200%; aligns variable cash to financial outcomes .
  • Retention risk mitigated: US$150k retention through Oct 1, 2025 and 18‑month non‑compete/non‑solicit reduce near‑term retention risk; severance provides 18 months’ salary + 150% of average STI, reinforcing stability but creating potential cash obligations on separation .
  • Equity alignment and potential supply: Meaningful equity exposure with options and RSUs; 38,423 units scheduled to vest within 60 days of Aug 1, 2025 could create modest near‑term selling/withholding flow; anti‑hedging policy supports alignment; no pledging disclosed .
  • CIC economics: No CIC cash multiple; equity acceleration is double‑trigger within 18 months post‑CIC, limiting windfall risk while preserving retention through potential change events .
  • Execution track record: Regulatory strategy and U.S. platform design (Canopy USA) plus prior M&A record support her role as a strategic operator; FY2025 margin/debt improvements provide context for incentive outcomes and future execution risk/return balance .